John Zhang

Person

Camarillo, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Calcitonin gene-related peptide (CGRP) antagonist antibodies
- Patent number 11,629,184
- Issue date Apr 18, 2023
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunotherapy using antibodies that bind programmed death ligand-1...
- Patent number 11,332,531
- Issue date May 17, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)
- Patent number 11,248,049
- Issue date Feb 15, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-OX40 antibodies and methods of activating OX40
- Patent number 11,242,398
- Issue date Feb 8, 2022
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HUMAN ENDOTHELIN RECEPTOR A (ETAR) ANTAGONIST ANTIBODIES
- Publication number 20230212300
- Publication date Jul 6, 2023
- REMD Biotherapeutics, Inc.
- Hai Yan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES
- Publication number 20230151104
- Publication date May 18, 2023
- REMD Biotherapeutics, Inc.
- Hai Yan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
CANCER TREATMENT USING ANTIBODIES THAT BIND HUMAN CD134 (OX40) RECE...
- Publication number 20210024640
- Publication date Jan 28, 2021
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CALCITONIN GENE-RELATED PEPTIDE (CGRP) ANTAGONIST ANTIBODIES
- Publication number 20200407433
- Publication date Dec 31, 2020
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH LIGAND-1...
- Publication number 20200190197
- Publication date Jun 18, 2020
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH 1 (PD-1)
- Publication number 20190330346
- Publication date Oct 31, 2019
- REMD Biotherapeutics, Inc.
- Frank J Calzone
- C07 - ORGANIC CHEMISTRY
Information Patent Application
POLYMERS IN BIOMASS SACCHARIFICATION BIOPROCESS
- Publication number 20160160252
- Publication date Jun 9, 2016
- EdeniQ, Inc.
- John Zhang
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Person

Patents Grantslast 30 patents

Calcitonin gene-related peptide (CGRP) antagonist antibodies

Immunotherapy using antibodies that bind programmed death ligand-1...

Immunotherapy using antibodies that bind Programmed Death 1 (PD-1)

Anti-OX40 antibodies and methods of activating OX40

Patents Applicationslast 30 patents

HUMAN ENDOTHELIN RECEPTOR A (ETAR) ANTAGONIST ANTIBODIES

CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST ANTIBODIES

CANCER TREATMENT USING ANTIBODIES THAT BIND HUMAN CD134 (OX40) RECE...

CALCITONIN GENE-RELATED PEPTIDE (CGRP) ANTAGONIST ANTIBODIES

IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH LIGAND-1...

IMMUNOTHERAPY USING ANTIBODIES THAT BIND PROGRAMMED DEATH 1 (PD-1)

POLYMERS IN BIOMASS SACCHARIFICATION BIOPROCESS